Risk Factors

TitleYear PublishedProduct Code
Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome2014NA
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update2011NA
Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth 2011NA
Guidelines for the Primary Prevention of Stroke2010KB-0080

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary 

2010KB-0113

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Full Text 

2010KB-0112
Impact of Smokeless Tobacco Products on Cardiovascular Disease2010KB-0079
Call to Action: Cardiovascular Disease in Asian Americans2010KB-0078
Translating Evidence Into Practice: A Decade of Efforts by the American Heart Association/American Stroke Association to Reduce Death and Disability Due to Stroke2010KB-0035
Thiazolidinedione Drugs and Cardiovascular Risks2010KB-0036

AHA/ACS/AUA Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk

2010KB-0015
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association’s Strategic Impact Goal Through 2020 and Beyond2010KB-0016
Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity2009KJ-0730
Worksite Wellness Programs for Cardiovascular Disease Prevention2009KJ-0733
Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents: Recommendations for Standard Assessment for Clinical Research2009KJ-0729
Exercise Training for Type 2 Diabetes Mellitus: Impact on Cardiovascular Risk2009LS-2091
Criteria for Evaluation of Novel Markers of Cardiovascular Risk2009LS-2042
Partnering to Reduce Risks and Improve Cardiovascular Outcomes2009LS-1939
The American Heart Association's 2008 Statement of Principles for Healthcare Reform2008---
Depression and Coronary Heart Disease: Recommendations for Screening, Referral, and Treatment200871-0456
Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary Prevention Programs2005

71-0337

Managing Abnormal Blood Lipids: A Collaborative Approach

2005

71-0332

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement: Executive Summary200571-0336
Exercise Testing in Asymptomatic Adults. A Statement for Professionals From the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention2005NA
Overweight in Children and Adolescents200571-0320
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease--Application to Clinical and Public Health Practice: Overview200471-0306
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease--Application to Clinical and Public Health Practice: Report From the Laboratory Science Discussion Group200471-0306
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease--Application to Clinical and Public Health Practice: Report From the Clinical Practice Discussion Group200471-0306
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease--Application to Clinical and Public Health Practice: Report From the Population Science Discussion Group200471-0306
AHA Scientific Statement: Air Pollution and Cardiovascular Disease200471-0289
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease200371-0258
AHA/CDC Scientific Statement: Markers of Inflammation and Cardiovascular Disease—Application to Clinical and Public Health Practice200371-0246
Cardiovascular Health in Childhood200271-0229
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins200271-0234
Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients ≥75 Years of Age)200271-0224
Exercise Standards for Testing and Training200171-0210
AHA Science Advisory Assessment of Functional Capacity in Clinical and Research Applications200071-0190
AHA/AACVPR Scientific Statement Core Components of Cardiac Rehabilitation/Secondary Prevention Programs200071-0186

Prevention Conference V: Beyond Secondary Prevention: Identifying the High-Risk Patient for Primary Prevention: Executive Summary

200071-0181
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations199971-0177
Diabetes and Cardiovascular Disease199971-0175
Primary Prevention of Coronary Heart Disease: Guidance From Framingham199871-0139
Optimal Risk Factor Management in the Patient After Coronary Revascularization199471-0062

Statements & Guidelines by Topic

S&G A-C S&G D-H

S&G I-P S&G Q-Z
S&G CirculationTen Years of Images from Circulation
This book contains over 400 of the best images from Circulation. Each of the excellent pictures is accompanied by a short two- to three-page commentary.